Elias Zerhouni, M.D., Head of Global Research and Development will retire from Sanofi on June 30th, 2018, after more than 9 years of distinguished service with the company. He will be succeeded in the post by John C. Reed, M.D. Ph.D. who has been appointed Head of Global Research & Development, as of July 1st, 2018.
Sanofi names John Reed as new Head of Global R&D
AppointmentsElias Zerhouni, M.D., Head of Global Research and Development will retire from Sanofi on June 30th, 2018, after more than 9 years of distinguished service with the company. He will be succeeded in the post by John C. Reed, M.D. Ph.D. who has been appointed Head of Global Research & Development, as of July 1st, 2018.
Can sustainable bioeconomy be a driver of Green Growth?
OpinionPalbociclib companion biomarker unraveled
Latest NewsResearchers at the Universities of Dundee and Newcastle have identified a previously unknown target for the breast cancer drug palbociclib, which can be used to identify treatment responders.
GMP and new processes: be prepared for hassle
BackgroundPoor aseptic practices can rapidly ruin market supply of products outsourced for production. This year, Celltrion came under fire from FDA inspectors. At the end of January, the producer received a warning letter affecting the production of Inflectra biosimilar infliximab-dyyb (CT- P13) co-marketed with Pfizer. In mid-February, the FDA added a warning concerning rituximab and trastuzumab biosimilars produced for Teva, as well as for its fast-track migraine mAb fremanezumab.
GBS 2018: Bioeconomy leaders foster shift to sustainable industry production
Latest NewsInternational collaboration is needed to secure living of the growing world population without collapse of the planet’s resources, biodiversity and climate. A communique published at the end of the Global Bioeconomy Summit (GBS) outlines policy measures needed to create a biobased economy for all.
A bioengineered tattoo monitors blood calcium levels
Latest NewsSwiss researchers have created a biomedical tattoo that becomes visible on the skin of mice in response to elevated levels of calcium in the blood.
German biotech sector growing
Latest NewsThe German biotech industry has shown tremendous growth in 2017. According to figures of BIOCOM, turnover, employees or number of start-ups – many key figures for 2017 exceeded those of the record year 2016.
Servier to bag Shire’s cancer business
Latest NewsFrench Servier boosts its cancer drug portfolio acquiring Shire plcs oncology pipeline, which earned about US$260m last year, for US$2.4bn in cash.
Germany to boost the bioeconomy
Latest NewsShortly before the Global Bioeconomy Summit (19.-20.4.2018) in Berlin will begin, Germany’s new Research Minister Anja Karliczek announced three major initiatives to strengthen the biologisation of the industry and the foundation of innovative biotechs.
Canopy acquires Czech Annabis Medical sro
Latest News